Schmitt, Clemens A. http://orcid.org/0000-0002-4731-2226
Tchkonia, Tamar
Niedernhofer, Laura J.
Robbins, Paul D. http://orcid.org/0000-0003-1068-7099
Kirkland, James L. http://orcid.org/0000-0003-1676-4905
Lee, Soyoung http://orcid.org/0000-0002-4614-2931
Article History
Accepted: 9 September 2022
First Online: 5 October 2022
Competing interests
: C.A.S. received travel support, honoraria and consulting fees from Abbvie, AstraZeneca, Bayer, Bristol-Myers Squibb/Celgene, Gilead/Kite, Janssen-Cilag, MSD, Novartis, Octapharma, Pierre Fabre, Roche, Sanofi, Takeda, and TissUse. Patents on senolytic drugs and their uses are held by Mayo Clinic (J.L.K. and T.T.) and the University of Minnesota (P.D.R. and L.J.N.). S.L. declares no competing interests.
Free to read: This content has been made available to all.